OrthoEvidence - AceReport

Previous Ace Report Similar outcomes with video-based and lecture-based education programs for osteoporosis patients Next Ace Report Similar outcomes with video-based and lecture-based education programs for osteoporosis patients

Tumour

Slight improvement in response with temozolamide plus radiotherapy vs radiotherapy alone for STS

Language

Download

Cite

+ Favorites

Language

Download

Cite

+ Favorites

TUMOUR

Slight improvement in response with temozolamide plus radiotherapy vs radiotherapy alone for STS

This report has been verified by one or more authors of the original publication.

Radiotherapy alone with concurrent chemoradiotherapy plus temozolamide in locally advanced soft tissue sarcoma at Mayo Hospital Lahore: A randomized controlled trial.

JPMA 70: 572. 2020 Apr 1;1:3-1.

Contributing Authors

MA Khokhar M Akhtar SFUHS Gillani R Abdulsalaam S Qamar

Sixty-four patients with soft tissue sarcomas (STS) were randomized to receive radiation therapy only or radiation therapy plus oral temozolomide. The primary outcome of interest was treatment response as measured by the Response Evaluation Criteria in Solid Tumours (RECIST) criteria. Secondary outcomes of interest included the incidence of adverse events. Results revealed a significantly higher incidence of rash in the combination group compared to the radiation only group. Whilst no significant differences were observed in all remaining outcomes, the number of patients with a positive treatment response was higher in the combination group, and the number of patients with cancer progression was lower in the combination group, compared to the radiation only group.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports

Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.

0 of 4 monthly FREE articles unlocked

You've reached your limit of 4 free articles views this month